FDA Adverse Event Injury Summary report: N

ASR XL TAP SLV ADAP 12/14+5

MDR report key: 2013159 · Received February 24, 2011

Report

Report Number
1818910-2011-02041
Event Type
Injury
Date Received
February 24, 2011
Date of Event
January 18, 2011
Report Date
January 25, 2011
Manufacturer
DEPUY INTERNATIONAL, LTD.
Product Code
KWA
PMA / PMN Number
NA
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4).

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Description of Event or Problem · 1

THE PT WAS REVISED TO ADDRESS PAIN AND ELEVATED SERUM AND COBALT CHROME LEVELS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ASR XL TAP SLV ADAP 12/14+5 87KWA KWA DEPUY INTERNATIONAL, LTD. NA 2398223

Patients

Seq Age Sex Outcome Treatment
1 69 YR Required Intervention